Healthy Subjects

Showing NaN - NaN of 16

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Subjects Trial (Camizestrant, Itraconazole)

Completed
  • Healthy Subjects
  • Harrow, United Kingdom
    Research Site
Jan 5, 2023

Healthy Subjects Trial in Harrow (AZD7798, Placebo)

Recruiting
  • Healthy Subjects
  • AZD7798
  • Placebo
  • Harrow, United Kingdom
    Research Site
Aug 12, 2022

Healthy Subjects Trial in Harrow (CKD-508 Capsule, Placebo Capsule, CKD-508 Tablet)

Recruiting
  • Healthy Subjects
  • CKD-508 Capsule
  • +3 more
  • Harrow, Middlesex, United Kingdom
    Northwick Park Hospital
Feb 4, 2022

Safety, Healthy Subjects Trial in Glendale, Harrow (MEDI9314, )

Completed
  • Safety
  • Healthy Subjects
  • Glendale, California
  • +1 more
May 23, 2019

Safety, Tolerability, Pharmacokinetics Trial in Harrow (AZD9977, oral suspension, Placebo, oral suspension, AZD9977, oral

Completed
  • Safety
  • +3 more
  • AZD9977, oral suspension
  • +2 more
  • Harrow, United Kingdom
    Research Site
Mar 28, 2017

Pharmacodynamics, Healthy Subjects Trial in Harrow (AZD9977 oral suspension, AZD9977 oral suspension, Fludrocortisone, tablets)

Completed
  • Pharmacodynamics
  • Healthy Subjects
  • AZD9977 oral suspension
  • +3 more
  • Harrow, United Kingdom
    Research Site
Feb 9, 2017

Healthy Subjects, Pharmacokinetics of ASP6294 Trial in Harrow (ASP6294 Intravenous, ASP6294 Subcutaneous, Placebo Intravenous)

Completed
  • Healthy Subjects
  • Pharmacokinetics of ASP6294
  • ASP6294 Intravenous
  • +3 more
  • Harrow, United Kingdom
    Site GB44001
Jan 9, 2017

Healthy Subjects, Pharmacokinetics of ASP2205 Trial in Harrow (ASP2205, Placebo)

Terminated
  • Healthy Subjects
  • Pharmacokinetics of ASP2205
  • Harrow, United Kingdom
    Site GB44001
Jun 17, 2016

Healthy Subjects Trial in Harrow (Pilocarpine, Placebo)

Completed
  • Healthy Subjects
  • Harrow, United Kingdom
    PAREXEL Early Phase Clinical Unit
Aug 10, 2015

Pharmacokinetics of ASP7657, Pharmacodynamics of ASP7657, Healthy Subjects Trial in Harrow (ASP7657, Placebo, naproxen)

Terminated
  • Pharmacokinetics of ASP7657
  • +2 more
  • Harrow, Middlesex, United Kingdom
    Parexel Early Phase Clinical Unit
Mar 26, 2015

EC905, Pharmacokinetics, Multiple Dose Trial in Harrow (EC905)

Completed
  • EC905
  • +3 more
  • Harrow, United Kingdom
    Parexel Early Phase Clinical Unit
May 28, 2014

EC905, Pharmacokinetics, Healthy Subjects Trial in Harrow (EC905)

Completed
  • EC905
  • +2 more
  • Harrow, United Kingdom
    Parexel Early Phase Clinical Unit
May 28, 2014

Healthy Subjects Trial in Harrow (ASP1707, Placebo)

Completed
  • Healthy Subjects
  • Harrow, United Kingdom
    Parexel Early Phase
May 21, 2014

Pharmacokinetics of ASP3652, Pharmacodynamics of ASP3652, Healthy Subjects Trial in Harrow (ASP3652)

Completed
  • Pharmacokinetics of ASP3652
  • +2 more
  • Harrow, United Kingdom
    PAREXEL Early Phase Clinical Unit
Jan 10, 2014

Pharmacokinetics, Pharmacodynamics, Healthy Subjects Trial in Harrow (ASP3652)

Completed
  • Pharmacokinetics
  • +3 more
  • Harrow, United Kingdom
    Parexel Early Phase Clinical Unit
Oct 4, 2013

Drug-Drug Interaction (DDI), Healthy Subjects Trial in Harrow (ASP3652, Gemfibrozil, Repaglinide)

Completed
  • Drug-Drug Interaction (DDI)
  • Healthy Subjects
  • Harrow, United Kingdom
    PAREXEL Early Phase Clinical Unit
Feb 20, 2013